Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I study

Cardiovascular Revascularization Medicine

Volumn 16, Issue 7, 2015, Pages 413-417

  Worthley, Stephen ^a   Hendriks, Randall ^b   Worthley, Matthew ^a   Whelan, Alan ^b   Walters, Darren L ^c,d   Whitbourn, Robert ^e   Meredith, Ian ^f  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

^c THE PRINCE CHARLES HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e ST VINCENT S HOSPITAL   (Australia)

^f MONASH MEDICAL CENTRE   (Australia)

Author keywords

Bifurcation lesion; Drug coated balloon; Drug eluting balloon; Provisional stenting

Indexed keywords

EVEROLIMUS; PACLITAXEL; BIOCOMPATIBLE COATED MATERIAL; CARDIOVASCULAR AGENT;

AGED; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ARTICLE; AUSTRALIA; BALLOON CATHETER; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY BIFURCATION LESION; EVEROLIMUS ELUTING CORONARY STENT; FEMALE; HEART INFARCTION; HUMAN; INTRAVASCULAR ULTRASOUND; MALE; MULTICENTER STUDY; PACLITAXEL ELUTING BALLOON; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOON; PRIORITY JOURNAL; RESTENOSIS; STENT THROMBOSIS; ADVERSE EFFECTS; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DEVICES; DRUG ELUTING STENT; FEASIBILITY STUDY; INTERVENTIONAL ULTRASONOGRAPHY; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PILOT STUDY; PROSPECTIVE STUDY; PROSTHESIS DESIGN; TIME FACTOR; TREATMENT OUTCOME; VASCULAR ACCESS DEVICE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AUSTRALIA; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; EVEROLIMUS; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PACLITAXEL; PERCUTANEOUS CORONARY INTERVENTION; PILOT PROJECTS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR ACCESS DEVICES;

EID: 84948116449     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2015.07.009     Document Type: Article

References (15)

1. Kleber F.X., Rittger H., Bonaventura K., Zeymer U., Wöhrle J., Jeger R., et al. Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group. Clin Res Cardiol 2013, 102:785-797.
2. Windecker S., Kolh P., Alfonso F., Collet J.P., Cremer J., Falk V., et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014, 35:2541-2619.
3. Lassen J.F., Holm N.R., Stankovic G., Lefèvre T., Chieffo A., Hildick-Smith D., et al. Percutaneous coronary intervention for coronary bifurcation disease: consensus from the first 10years of the European Bifurcation Club meetings. EuroIntervention 2014, 10:545-560.
4. Latib A., Colombo A. Bifurcation disease: what do we know, what should we do?. JACC Cardiovasc Interv 2008, 1:218-226.
5. Loh J.P., Barbash I.M., Waksman R. The current status of drug-coated balloons in percutaneous coronary and peripheral interventions. EuroIntervention 2013, 9(8):979-988.
6. Mathey D.G., Wendig I., Boxberger M., Bonaventura K., Kleber F.X. Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease). EuroIntervention 2011, 7(Suppl. K):K61-K65.
7. Herrador J.A., Fernandez J.C., Guzman M., Aragon V. Drug-eluting vs. conventional balloon for side branch dilation in coronary bifurcations treated by provisional T stenting. J Interv Cardiol 2013, 26:454-462.
8. Joner M., Byrne R.A., Lapointe J.M., Radke P.W., Bayer G., Steigerwald K., et al. Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis. Thromb Haemost 2011, 105:864-872.
9. Joner M., Radke P.W., Byrne R.A., Hartwig S., Steigerwald K., Leclerc G., et al. Preclinical evaluation of a novel drug-eluting balloon in an animal model of in-stent stenosis. J Biomater Appl 2013, 27:717-726.
10. Medina A., Suárez de Lezo J., Pan M. A new classification of coronary bifurcation lesions. Rev Esp Cardiol 2006, 59:183.
11. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007, 115:2344-2351.
12. Stella P.R., Belkacemi A., Dubois C., Nathoe H., Dens J., Naber C., et al. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial. Catheter Cardiovasc Interv 2012, 80:1138-1146.
13. López Mínguez J.R., Nogales Asensio J.M., Doncel Vecino L.J., Sandoval J., Romany S., Martinez Romero P., et al. A prospective randomised study of the paclitaxel-coated balloon catheter in bifurcated coronary lesions (BABILON trial): 24-month clinical and angiographic results. EuroIntervention 2014, 10:50-57.
14. Niemelä M., Kervinen K., Erglis A., Holm N.R., Maeng M., Christiansen E.H., et al. Randomized comparison of final kissing balloon dilatation versus no final kissing balloon dilatation in patients with coronary bifurcation lesions treated with main vessel stenting: the Nordic-Baltic Bifurcation Study III. Circulation 2011, 123:79-86.
15. Chakrabarti A.K., Grau-Sepulveda M.V., O'Brien S., Abueg C., Ponirakis A., Delong E., et al. Angiographic validation of the American College of Cardiology Foundation-the Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies study. Circ Cardiovasc Interv 2014, 7:11-18.